Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

por Solares, Ana M, Santana, Agueda, Baladrón, Idania, Valenzuela, Carmen, González, Carlos A, Díaz, Alina, Castillo, Dagnelia, Ramos, Thelvia, Gómez, Roberto, Alonso, Daniel F, Herrera, Luis, Sigman, Hugo, Perea, Silvio E, Acevedo, Boris E, López-Saura, Pedro
Publicado 2009

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial

por Solares, Ana M., Baladron, Idania, Ramos, Thelvia, Valenzuela, Carmen, Borbon, Zaida, Fanjull, Sonia, Gonzalez, Leonardo, Castillo, Dagnelia, Esmir, Julio, Granadillo, Milaid, Batte, Aileen, Cintado, Alberto, Ale, Mayte, Fernandez de Cossio, Maria E., Ferrer, Annia, Torrens, Isis, Lopez-Saura, Pedro
Publicado 2011